Drug shortages homepage

Welcome to Drug Shortages Canada, the website for mandatory reporting of drug shortages and discontinuations by market authorization holders. Anyone can search the database of shortage and discontinuation reports. More information can be found on the About & Resources Page.

Early reporting of shortages and discontinuations provides Health Canada, provincial/territorial governments, drug supply chain stakeholders, and health professionals details needed to help them monitor and manage supply. Shortages can be caused by many factors. Some last longer and are more complex than others. Because companies have to report every time they cannot fully meet demand, not all of the reports on this site are cause for concern at the patient level. Most are successfully managed before they impact patients.

The shortage database has a flag that indicates ones that are Tier 3 drug shortages, which are those that could potentially have the highest impact on Canada's drug supply and health care system. A Tier 3 designation is decided by the Tier Assignment Committee (TAC), composed of federal and provincial/territorial governments, healthcare professionals, and industry stakeholders.

Ensuring people can get the medicines they need is a top priority for Health Canada. Health Canada works closely with many partners to prevent shortages, mitigate their impacts, and help resolve them when they occur.

If you would like to know more about shortages like why they happen, how long they last, the actions being taken to reduce impacts on Canadians, and actions you can take if a drug you use is in shortage, please consult the information on Canada.ca.

Below are the newest shortage and discontinuation reports and updates to existing ones.

Drug pills

LEGEND

!!T3 denotes an actual Tier 3 shortage/discontinuation

!T3 denotes an anticipated Tier 3 shortage/discontinuation

Shortage Reports

Brand name Company Name Status Strength Update Date Updated View Report
ENALAPRILAT INJECTION USP HIKMA CANADA LIMITED Actual shortage 1.25MG Updated Report 2024-05-23 213843
SANDOZ TAMSULOSIN CR SANDOZ CANADA INCORPORATED Actual shortage 0.4MG Updated Report 2024-05-23 228446
SANDOZ TAMSULOSIN CR SANDOZ CANADA INCORPORATED Actual shortage 0.4MG Updated Report 2024-05-23 228441
ULTRATAG RBC CURIUM CANADA INC Actual shortage 20MCI Updated Report 2024-05-23 228585
TEVA-TAMOXIFEN TEVA CANADA LIMITED Actual shortage 20MG Updated Report 2024-05-23 219038
TEVA-ESOMEPRAZOLE TEVA CANADA LIMITED Resolved 20MG Updated Report 2024-05-23 221552
TEVA-DONEPEZIL TEVA CANADA LIMITED Resolved 5MG Updated Report 2024-05-23 222941
TEVA-TOPIRAMATE TEVA CANADA LIMITED Resolved 25MG Updated Report 2024-05-23 224889
TEVA-LENOLTEC NO. 3 TEVA CANADA LIMITED Resolved 300MG 30MG 15MG Updated Report 2024-05-23 225477
TEVA-CEPHALEXIN 250 TEVA CANADA LIMITED Resolved 250MG Updated Report 2024-05-23 220977
TEVA-MOMETASONE TEVA CANADA LIMITED Actual shortage 50MCG Updated Report 2024-05-23 215760
TEVA-LACOSAMIDE TEVA CANADA LIMITED Actual shortage 50MG Updated Report 2024-05-23 222575
TEVA-BUPRENORPHINE/NALOXONE TEVA CANADA LIMITED Actual shortage 2MG 8MG Updated Report 2024-05-23 221537
ACT METHYLPHENIDATE ER TEVA CANADA LIMITED Actual shortage 54MG Updated Report 2024-05-23 228143
TEVA-AMPHETAMINE XR TEVA CANADA LIMITED Actual shortage 20MG Updated Report 2024-05-23 224904
TEVA-DUTASTERIDE TEVA CANADA LIMITED Actual shortage 0.5MG Updated Report 2024-05-23 184216
TEVA-SOLIFENACIN TEVA CANADA LIMITED Actual shortage 10MG Updated Report 2024-05-23 195481
TEVA-SOLIFENACIN TEVA CANADA LIMITED Actual shortage 10MG Updated Report 2024-05-23 195456
TEVA-SOLIFENACIN TEVA CANADA LIMITED Actual shortage 5MG Updated Report 2024-05-23 195652
TEVA-SOLIFENACIN TEVA CANADA LIMITED Actual shortage 5MG Updated Report 2024-05-23 151465

Discontinuation Reports

Brand name Company Name Status Strength Update Date Updated View Report
VITAMIN A ACID BAUSCH HEALTH, CANADA INC. Discontinued 0.01% Updated Report 2024-05-23 217835
HEPARIN SODIUM INJECTION USP (MULTIDOSE VIAL-WITH PRESERVATIVE) SANDOZ CANADA INCORPORATED Discontinued 10000UNIT Updated Report 2024-05-18 228249
SANDOZ PRAVASTATIN TABLETS SANDOZ CANADA INCORPORATED Discontinued 20MG Updated Report 2024-05-18 228256
SANDOZ PRAVASTATIN TABLETS SANDOZ CANADA INCORPORATED Discontinued 40MG Updated Report 2024-05-18 228263
SANDOZ SENNA S SANDOZ CANADA INCORPORATED Discontinued 50MG 8.6MG Updated Report 2024-05-18 228268
SUPREFACT DEPOT 3 MONTHS CHEPLAPHARM ARZNEIMITTEL GMBH Discontinued 9.45MG Updated Report 2024-05-17 228166
ANANDRON CHEPLAPHARM ARZNEIMITTEL GMBH Discontinued 50MG Updated Report 2024-05-17 228155
FOSRENOL TAKEDA CANADA INC To be discontinued 1000MG New Report 2024-05-16 228184
FOSRENOL TAKEDA CANADA INC To be discontinued 750MG New Report 2024-05-16 228181
FOSRENOL TAKEDA CANADA INC To be discontinued 500MG New Report 2024-05-16 228178